Treatment of behavioral disorders with &bgr;-lactam compounds
US6627625B1 · kind B1 · utility
19Cited by
19References
38Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 16, 2000 |
| Grant date | Sep 30, 2003 |
| Priority date | — |
| Expiry date | Aug 16, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Administration of &bgr;-lactam compounds including &bgr;-lactam antibiotics and &bgr;-lactamase inhibitors provides significant neurotropic effects in warm-blooded vertebrates evidenced inter alia by anxiolytic and anti-aggressive behavior modification and enhanced cognition. Therapeutic methods for using such compounds and their pharmaceutical formulations are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.